Αρχειοθήκη ιστολογίου

Τρίτη 4 Ιουλίου 2017

Precision medicine enabled histology agnostic development of immunotherapeutics

Prof Baynes speaks with ecancer at WIN 2017 about design and development of immune therapies sensitive to mutational deficiencies in the DNA repair pathway He notes the recent approval of pembrolizumab (Keytruda) PD1 therapy for relapsed cancer...

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2tNsJ2i
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader